Healthcare & Life Sciences
Ermium Therapeutics
Franceermium.com
Ermium Therapeutics is a Healthcare & Life Sciences startup based in France, most recent round Seed, 1 tracked investor.
Defunctseed
seed
Stage
1
Investors
About Ermium Therapeutics
Ermium Therapeutics is a startup based in France. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Ermium Therapeutics was a biotechnology company developing functionally selective immunomodulators targeting the CXCR4 receptor for autoimmune diseases, particularly interferonopathies such as systemic lupus erythematosus (SLE). The company ceased operations in 2024.
Explore Ermium Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.